Home > Balance Sheet > GLAND PHARMA

GLAND PHARMA
Balance Sheet

GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Top Undervalued Mid Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Balance Sheet History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020
EQUITY AND LIABILITIES
Share Capital ₹16 Cr₹16 Cr₹16 Cr₹15 Cr
    Equity - Authorised ₹50 Cr₹50 Cr₹50 Cr₹50 Cr
    Equity - Issued ₹16 Cr₹16 Cr₹16 Cr₹15 Cr
    Equity Paid Up ₹16 Cr₹16 Cr₹16 Cr₹15 Cr
    Equity Shares Forfeited ----
    Adjustments to Equity ----
    Preference Capital Paid Up ----
    Face Value ₹1.00₹1.00₹1.00₹1.00
Share Warrants & Outstandings ₹1.67 Cr₹13 Cr₹25 Cr₹16 Cr
Total Reserves ₹7,941 Cr₹7,128 Cr₹5,861 Cr₹3,614 Cr
    Securities Premium ₹1,928 Cr₹1,895 Cr₹1,840 Cr₹589 Cr
    Capital Reserves ----
    Profit & Loss Account Balance ₹6,015 Cr₹5,234 Cr₹4,023 Cr₹3,026 Cr
    General Reserves ₹3.12 Cr₹3.12 Cr₹3.12 Cr₹3.12 Cr
    Other Reserves ₹-6.35 Cr₹-4.91 Cr₹-4.45 Cr₹-3.58 Cr
Reserve excluding Revaluation Reserve ₹7,941 Cr₹7,128 Cr₹5,861 Cr₹3,614 Cr
Revaluation reserve ----
Shareholder's Funds ₹7,959 Cr₹7,158 Cr₹5,903 Cr₹3,646 Cr
Minority Interest ----
Long-Term Borrowings ----
Secured Loans ----
    Non Convertible Debentures ----
    Converible Debentures & Bonds ----
    Packing Credit - Bank ----
    Inter Corporate & Security Deposit ----
    Term Loans - Banks ----
    Term Loans - Institutions ----
    Other Secured ----
Unsecured Loans ₹3.26 Cr₹3.82 Cr₹3.93 Cr₹4.07 Cr
    Fixed Deposits - Public ----
    Loans and advances from subsidiaries ----
    Inter Corporate Deposits (Unsecured) ----
    Foreign Currency Convertible Notes ----
    Long Term Loan in Foreign Currency ----
    Loans - Banks ----
    Loans - Govt. ----
    Loans - Others ----
    Other Unsecured Loan ₹3.26 Cr₹3.82 Cr₹3.93 Cr₹4.07 Cr
Deferred Tax Assets / Liabilities ₹84 Cr₹88 Cr₹74 Cr₹74 Cr
    Deferred Tax Assets ₹23 Cr₹7.65 Cr₹6.02 Cr₹6.05 Cr
    Deferred Tax Liability ₹107 Cr₹95 Cr₹80 Cr₹80 Cr
Other Long Term Liabilities ₹2.22 Cr₹2.39 Cr₹2.50 Cr₹2.66 Cr
Long Term Trade Payables ----
Long Term Provisions ----
Total Non-Current Liabilities ₹90 Cr₹94 Cr₹80 Cr₹81 Cr
Current Liabilities ----
Trade Payables ₹587 Cr₹463 Cr₹396 Cr₹249 Cr
    Sundry Creditors ₹587 Cr₹463 Cr₹396 Cr₹249 Cr
    Acceptances ----
    Due to Subsidiaries- Trade Payables ----
Other Current Liabilities ₹109 Cr₹76 Cr₹62 Cr₹82 Cr
    Bank Overdraft / Short term credit ----
    Advances received from customers ₹76 Cr₹34 Cr₹34 Cr₹34 Cr
    Interest Accrued But Not Due ----
    Share Application Money ----
    Current maturity of Debentures & Bonds ----
    Current maturity - Others ----
    Other Liabilities ₹33 Cr₹43 Cr₹28 Cr₹47 Cr
Short Term Borrowings ----
    Secured ST Loans repayable on Demands ----
    Working Capital Loans- Sec ----
    Buyers Credits - Unsec ----
    Commercial Borrowings- Unsec ----
    Other Unsecured Loans ----
Short Term Provisions ₹32 Cr₹43 Cr₹54 Cr₹28 Cr
    Proposed Equity Dividend ----
    Provision for Corporate Dividend Tax ----
    Provision for Tax ₹0.99 Cr₹18 Cr₹29 Cr₹11 Cr
    Provision for post retirement benefits ----
    Preference Dividend ----
    Other Provisions ₹31 Cr₹25 Cr₹25 Cr₹17 Cr
Total Current Liabilities ₹729 Cr₹582 Cr₹513 Cr₹359 Cr
Total Liabilities ₹8,778 Cr₹7,834 Cr₹6,496 Cr₹4,086 Cr
ASSETS
Gross Block ₹2,295 Cr₹2,081 Cr₹1,431 Cr₹1,348 Cr
Less: Accumulated Depreciation ₹724 Cr₹579 Cr₹476 Cr₹380 Cr
Less: Impairment of Assets ----
Net Block ₹1,571 Cr₹1,502 Cr₹954 Cr₹968 Cr
Lease Adjustment A/c ----
Capital Work in Progress ₹177 Cr₹181 Cr₹338 Cr₹188 Cr
Non Current Investments ----
Long Term Investment ----
    Quoted ----
    Unquoted ----
Long Term Loans & Advances ₹129 Cr₹286 Cr₹78 Cr₹82 Cr
Other Non Current Assets -₹2.21 Cr₹2.43 Cr₹1.66 Cr
Total Non-Current Assets ₹1,877 Cr₹1,982 Cr₹1,372 Cr₹1,240 Cr
Current Assets Loans & Advances ----
Currents Investments -₹155 Cr--
    Quoted ----
    Unquoted -₹155 Cr--
Inventories ₹1,945 Cr₹1,186 Cr₹1,275 Cr₹756 Cr
    Raw Materials ₹979 Cr₹466 Cr₹530 Cr₹302 Cr
    Work-in Progress ₹461 Cr₹444 Cr₹364 Cr₹198 Cr
    Finished Goods ₹82 Cr₹46 Cr₹170 Cr₹64 Cr
    Packing Materials ₹361 Cr₹176 Cr₹172 Cr₹156 Cr
    Stores Ā and Spare ₹41 Cr₹39 Cr₹33 Cr₹30 Cr
    Other Inventory ₹20 Cr₹15 Cr₹6.33 Cr₹6.52 Cr
Sundry Debtors ₹871 Cr₹1,075 Cr₹671 Cr₹602 Cr
    Debtors more than Six months ₹17 Cr₹12 Cr₹111 Cr-
    Debtors Others ₹913 Cr₹1,068 Cr₹561 Cr₹607 Cr
Cash and Bank ₹3,771 Cr₹3,093 Cr₹3,006 Cr₹1,325 Cr
    Cash in hand ₹0.01 Cr₹0.02 Cr₹0.02 Cr₹0.07 Cr
    Balances at Bank ₹3,771 Cr₹3,093 Cr₹3,006 Cr₹1,325 Cr
    Other cash and bank balances ----
Other Current Assets ₹91 Cr₹97 Cr₹84 Cr₹71 Cr
    Interest accrued on Investments ₹66 Cr₹47 Cr₹39 Cr₹15 Cr
    Interest accrued on Debentures ----
    Deposits with Government ----
    Interest accrued and or due on loans ----
    Prepaid Expenses ₹14 Cr₹14 Cr₹11 Cr₹9.12 Cr
    Other current_assets ₹12 Cr₹36 Cr₹34 Cr₹47 Cr
Short Term Loans and Advances ₹222 Cr₹247 Cr₹88 Cr₹92 Cr
    Advances recoverable in cash or in kind ₹120 Cr₹178 Cr₹13 Cr₹15 Cr
    Advance income tax and TDS ---₹9.54 Cr
    Amounts due from directors ----
    Due From Subsidiaries ----
    Inter corporate deposits ----
    Corporate Deposits ----
    Other Loans & Advances ₹102 Cr₹68 Cr₹75 Cr₹67 Cr
Total Current Assets ₹6,901 Cr₹5,852 Cr₹5,124 Cr₹2,846 Cr
Net Current Assets (Including Current Investments) ₹6,172 Cr₹5,270 Cr₹4,611 Cr₹2,487 Cr
Miscellaneous Expenses not written off ----
Total Assets ₹8,778 Cr₹7,834 Cr₹6,496 Cr₹4,086 Cr
Contingent Liabilities ₹22 Cr₹13 Cr₹75 Cr₹12 Cr
Total Debt ₹3.82 Cr₹3.93 Cr₹4.07 Cr₹4.96 Cr
Book Value 483.12434.84359.30234.25
Adjusted Book Value 483.12434.84359.30234.25

Compare Balance Sheet of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹28,945.2 Cr 0.8% -3.9% 45.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹356,625.0 Cr 3% 2.3% 68.2% Stock Analytics
CIPLA ₹113,471.0 Cr 2.5% 0.4% 71.7% Stock Analytics
DIVIS LABORATORIES ₹101,960.0 Cr -1.6% -7% 23.8% Stock Analytics
DR REDDYS LABORATORIES ₹99,276.9 Cr -0.2% -4.9% 40.3% Stock Analytics
ZYDUS LIFESCIENCES ₹93,921.9 Cr 5% 10.4% 109.1% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

0.8%

-3.9%

45.7%

SENSEX

1.3%

2.6%

24%


You may also like the below Video Courses